113 related articles for article (PubMed ID: 10597316)
1. Ras stimulates DNA topoisomerase II alpha through MEK: a link between oncogenic signaling and a therapeutic target.
Chen G; Templeton D; Suttle DP; Stacey DW
Oncogene; 1999 Nov; 18(50):7149-60. PubMed ID: 10597316
[TBL] [Abstract][Full Text] [Related]
2. junB promoter regulation: Ras mediated transactivation by c-Ets-1 and c-Ets-2.
Coffer P; de Jonge M; Mettouchi A; Binetruy B; Ghysdael J; Kruijer W
Oncogene; 1994 Mar; 9(3):911-21. PubMed ID: 8108135
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Raf-1 signaling by a monoclonal antibody, which interferes with Raf-1 activation and with Mek substrate binding.
Kolch W; Philipp A; Mischak H; Dutil EM; Mullen TM; Feramisco JR; Meinkoth JL; Rose DW
Oncogene; 1996 Sep; 13(6):1305-14. PubMed ID: 8808705
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic Ras can induce transcriptional activation through a variety of promoter elements, including tandem c-Ets-2 binding sites.
Galang CK; Der CJ; Hauser CA
Oncogene; 1994 Oct; 9(10):2913-21. PubMed ID: 8084596
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway.
Paumelle R; Tulasne D; Kherrouche Z; Plaza S; Leroy C; Reveneau S; Vandenbunder B; Fafeur V
Oncogene; 2002 Apr; 21(15):2309-19. PubMed ID: 11948414
[TBL] [Abstract][Full Text] [Related]
7. Structural and functional analysis of the control region of the human DNA topoisomerase II alpha gene in drug-resistant cells.
Takano H; Ise T; Nomoto M; Kato K; Murakami T; Ohmori H; Imamura T; Nagatani G; Okamoto T; Ohta R; Furukawa M; Shibao K; Izumi H; Kuwano M; Kohno K
Anticancer Drug Des; 1999 Apr; 14(2):87-92. PubMed ID: 10405635
[TBL] [Abstract][Full Text] [Related]
8. The activity of the Ets transcription factor PEA3 is regulated by two distinct MAPK cascades.
O'Hagan RC; Tozer RG; Symons M; McCormick F; Hassell JA
Oncogene; 1996 Sep; 13(6):1323-33. PubMed ID: 8808707
[TBL] [Abstract][Full Text] [Related]
9. A novel potential effector of M-Ras and p21 Ras negatively regulates p21 Ras-mediated gene induction and cell growth.
Ehrhardt GR; Korherr C; Wieler JS; Knaus M; Schrader JW
Oncogene; 2001 Jan; 20(2):188-97. PubMed ID: 11313946
[TBL] [Abstract][Full Text] [Related]
10. A role for the small GTPase Rac in polyomavirus middle-T antigen-mediated activation of the serum response element and in cell transformation.
Urich M; Senften M; Shaw PE; Ballmer-Hofer K
Oncogene; 1997 Mar; 14(10):1235-41. PubMed ID: 9121774
[TBL] [Abstract][Full Text] [Related]
11. The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression.
Barradas M; Monjas A; Diaz-Meco MT; Serrano M; Moscat J
EMBO J; 1999 Nov; 18(22):6362-9. PubMed ID: 10562548
[TBL] [Abstract][Full Text] [Related]
12. Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway.
Maida Y; Kyo S; Kanaya T; Wang Z; Yatabe N; Tanaka M; Nakamura M; Ohmichi M; Gotoh N; Murakami S; Inoue M
Oncogene; 2002 Jun; 21(26):4071-9. PubMed ID: 12037663
[TBL] [Abstract][Full Text] [Related]
13. c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK.
Deng T; Karin M
Nature; 1994 Sep; 371(6493):171-5. PubMed ID: 8072547
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-1 stimulates rat prolactin gene expression by a Ras, ETS and phosphatidylinositol 3-kinase dependent mechanism.
Castillo AI; Tolon RM; Aranda A
Oncogene; 1998 Apr; 16(15):1981-91. PubMed ID: 9591782
[TBL] [Abstract][Full Text] [Related]
15. Selective use of an alternative stop codon and polyadenylation signal within intron sequences leads to a truncated topoisomerase II alpha messenger RNA and protein in human HL-60 leukemia cells selected for resistance to mitoxantrone.
Harker WG; Slade DL; Parr RL; Holguin MH
Cancer Res; 1995 Nov; 55(21):4962-71. PubMed ID: 7585537
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.
Lok CN; Lang AJ; Mirski SE; Cole SP
Biochem J; 2002 Dec; 368(Pt 3):741-51. PubMed ID: 12197834
[TBL] [Abstract][Full Text] [Related]
17. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
18. SCH 51344 inhibits ras transformation by a novel mechanism.
Kumar CC; Prorock-Rogers C; Kelly J; Dong Z; Lin JJ; Armstrong L; Kung HF; Weber MJ; Afonso A
Cancer Res; 1995 Nov; 55(21):5106-17. PubMed ID: 7585559
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II type 1 receptor signals through Raf-1 by a protein kinase C-dependent, Ras-independent mechanism.
Arai H; Escobedo JA
Mol Pharmacol; 1996 Sep; 50(3):522-8. PubMed ID: 8794890
[TBL] [Abstract][Full Text] [Related]
20. Influence of cell cycle and oncogene activity upon topoisomerase IIalpha expression and drug toxicity.
Stacey DW; Hitomi M; Chen G
Mol Cell Biol; 2000 Dec; 20(24):9127-37. PubMed ID: 11094065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]